Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Disability
Article
Secrets to a Successful Stay At Work Program
A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge.
Workers' Comp
Blog
Investigating the Top Therapeutic Classes
First Script saw a decrease in opioid utilization across our retail and mail-order programs in 2018.
Disability
Article
Secrets to a Successful Stay At Work Program
A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge.
Workers' Comp
Article
Opioids in 2019: Insights into New Regulations and Studies of the Epidemic
Momentum in battling the opioid crisis continues.
Workers' Comp
Article
How Naloxone Can Help Fight the Opioid Crisis
Workers' Comp
Blog
Morphine Equivalent Dose (MED) Continues to Decline
In 2018 Coventry’s pharmacy benefit management solution, First Script®, saw a 7.8% decrease in average MED per prescription for its retail and mail